Stocks to Watch Monday: Berkshire Hathaway, Onsemi, Palantir -- WSJ

Dow Jones
2025/11/03

By WSJ Staff

Berkshire Hathaway (BRK.B, BRK.A): Warren Buffett's conglomerate said earnings rose 17% after its insurance business picked up last quarter. Plus, its trove of cash and equivalents hit a record high. Shares rose more than 1% in premarket trading.

Pfizer $(PFE)$: The drugmaker sued to block Metsera $(MTSR)$ from terminating their multibillion-dollar merger deal, after Novo Nordisk (DK:NOVO.B, NVO) made an unsolicited, rival takeover bid.

ON Semiconductor $(ON)$: The semiconductor-components maker is due to report quarterly earnings this morning. Shares rose premarket, as did other chip stocks, including Nvidia (NVDA) and Micron Technology $(MU)$.

Palantir (PLTR): The artificial-intelligence data-analysis company is due to post results this afternoon. Shares gained nearly 2% before the bell.

Aurinia Pharmaceuticals $(AUPH)$: The Canadian pharmaceutical company sued a Food and Drug Administration official. Dr. George Tidmarsh, who was hired to lead the FDA's drug division in July, resigned from the agency on Sunday.

CompoSecure (CMPO): The credit-card manufacturer is set to acquire Husky Technologies, a molding-equipment provider, from Platinum Equity for roughly $5 billion, including debt, The Wall Street Journal reported.

Ryanair (IE:RYA, RYAAY): The Irish budget airline posted an increase in first-half net profit that beat estimates. It said earlier-than-expected deliveries of Boeing $(BA)$ aircraft would allow it to carry more passengers in fiscal 2026 than previously forecast. However, shares fell more than 2%.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

November 03, 2025 04:49 ET (09:49 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10